UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Ten‐year update of the international registry on cytokine‐induced killer cells in cancer immunotherapy

Journal of cellular physiology, 2020-12, Vol.235 (12), p.9291-9303

2020

Link zum Volltext

Verfügbarkeit prüfen

Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)

Journal of cancer research and clinical oncology, 2015-05, Vol.141 (5), p.839-849

2015

Link zum Volltext

Verfügbarkeit prüfen

30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective

Journal of experimental & clinical cancer research, 2021-12, Vol.40 (1), p.388-388, Article 388

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

Journal of cancer research and clinical oncology, 2011-02, Vol.137 (2), p.305-310

2011

Link zum Volltext

Verfügbarkeit prüfen

Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5626

2023

Link zum Volltext

Verfügbarkeit prüfen

Improvements in Flow Cytometry‐Based Cytotoxicity Assay

Cytometry. Part A, 2021-07, Vol.99 (7), p.680-688

2021

Link zum Volltext

Verfügbarkeit prüfen

Systematic integration of m6A regulators and autophagy-related genes in combination with long non-coding RNAs predicts survival in glioblastoma multiforme

Scientific reports, 2023-10, Vol.13 (1), p.17232-17232, Article 17232

2023

Link zum Volltext

Verfügbarkeit prüfen

How shared is decision‐making in multidisciplinary tumour conferences with patient participation? An observational study

Health expectations : an international journal of public participation in health care and health policy, 2022-12, Vol.25 (6), p.3297-3306

2022

Link zum Volltext

Verfügbarkeit prüfen

Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment

BMC medical genomics, 2023-11, Vol.16 (1), p.295-295, Article 295

2023

Link zum Volltext

Verfügbarkeit prüfen

Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma

International journal of molecular sciences, 2023-08, Vol.24 (15), p.12476

2023

Link zum Volltext

Verfügbarkeit prüfen

Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome

BMC cancer, 2020-04, Vol.20 (1), p.355-355, Article 355

2020

Link zum Volltext

Verfügbarkeit prüfen

Patient participation in multidisciplinary tumor conferences in breast and gynecological cancer care: How patient‐centered is the communication?

Psycho-oncology (Chichester, England), 2022-09, Vol.31 (9), p.1597-1606

2022

Link zum Volltext

Verfügbarkeit prüfen

Cross-sectional increase of adherence to multidisciplinary tumor board decisions

BMC cancer, 2018-09, Vol.18 (1), p.936-936, Article 936

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma

Annals of neurology, 2010-02, Vol.67 (2), p.182-189

2010

Link zum Volltext

Verfügbarkeit prüfen

Long‐term follow‐up of Cladribine, high‐dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review

European journal of haematology, 2020-06, Vol.104 (6), p.538-545

2020

Link zum Volltext

Verfügbarkeit prüfen

Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma

Hematological oncology, 2017-12, Vol.35 (4), p.719-725

2017

Link zum Volltext

Verfügbarkeit prüfen

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2007-05, Vol.356 (22), p.2271-2281

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors

Journal of immunology research, 2014-01, Vol.2014, p.897214-12

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy

International journal of molecular sciences, 2019-09, Vol.20 (17), p.4307

2019

Link zum Volltext

Verfügbarkeit prüfen

Hairy cell leukemia: short review, today's recommendations and outlook

Blood cancer journal (New York), 2014-02, Vol.4 (2), p.e184-e184

2014

Link zum Volltext

Verfügbarkeit prüfen

Tempering of exhausted T cells to comprehend their adaptive response for suitable clinical translation

Cellular & molecular immunology, 2023-12, Vol.20 (12), p.1401-1402

2023

Link zum Volltext

Verfügbarkeit prüfen

Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1311

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

Leukemia, 2015-08, Vol.29 (8), p.1721-1729

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 435

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(405)
Mit Volltextzugriff
(396)

Publikationsform

Sprache

Englisch
(412)
Japanisch
(38)
Deutsch
(35)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(21)
Anticancer Research
(20)
Journal Of Clinical Oncology
(16)
Annals Of Hematology
(11)
German Medical Science
(10)
International Journal Of Molecular Sciences
(9)
Haematologica
(8)
In Vivo
(8)
British Journal Of Cancer
(7)
Cancer Gene Therapy
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Ten‐year update of the international registry on cytokine‐induced killer cells in cancer immunotherapy

Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)

30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors

Improvements in Flow Cytometry‐Based Cytotoxicity Assay

Systematic integration of m6A regulators and autophagy-related genes in combination with long non-coding RNAs predicts survival in glioblastoma multiforme

How shared is decision‐making in multidisciplinary tumour conferences with patient participation? An observational study

Balancing the interplay of histone deacetylases and non-coding genomes: a step closer to understand the landscape of cancer treatment

Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma

Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome

Patient participation in multidisciplinary tumor conferences in breast and gynecological cancer care: How patient‐centered is the communication?

Cross-sectional increase of adherence to multidisciplinary tumor board decisions

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma

Long‐term follow‐up of Cladribine, high‐dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review

Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial

Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors

Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy

Hairy cell leukemia: short review, today's recommendations and outlook

Tempering of exhausted T cells to comprehend their adaptive response for suitable clinical translation

Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

Suchergebnisse filtern